Zeria Pharmaceutical Co., Ltd.

4559・Prime Market・Pharmaceuticals

Official website

Zeria Pharmaceutical Co., Ltd.

4559・Prime Market・Pharmaceuticals

Official website

Zeria Pharmaceutical Co., Ltd.4559

Reference Indicators

Market Cap

1,049¥100M

P/E (Forecast)

—

P/B

0.9x

Dividend Yield (Forecast)

2.39%

ROE

8.5%

EV/EBITDA

5.9x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	59,532	68,383	75,725	87,311	89,159
Cost of Sales	17,384	18,894	20,223	23,351	23,976
Gross Profit	42,148	49,488	55,501	63,959	65,182
SG&A Expenses	35,782	40,473	45,879	51,762	52,808
Operating Income	6,366	9,014	9,621	12,197	12,374
Non-operating Income	287	379	652	1,502	780
Non-operating Expenses	717	1,815	1,761	859	2,111
Ordinary Income	5,935	7,579	8,513	12,840	11,043
Extraordinary Income	18	21	1,479	2	168
Extraordinary Losses	231	328	483	225	11
Pre-tax Income	5,721	7,272	9,508	12,618	11,200
Income Taxes	1,746	1,065	1,813	2,650	2,782
Net Income	3,961	6,195	7,731	9,936	8,454
EBITDA	11,766	15,163	16,439	19,752	19,721
Gross Margin	70.8%	72.4%	73.3%	73.3%	73.1%
Operating Margin	10.7%	13.2%	12.7%	14.0%	13.9%
ROA	3.2%	4.6%	5.1%	6.2%	4.7%
ROE	7.1%	10.3%	10.7%	11.7%	8.5%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医療用医薬品事業	61,625	12,176	19.8%
コンシューマーヘルスケア事業	27,382	6,360	23.2%
その他	150	201	134.0%